Anixa Biosciences, Inc.

twitter logo
Nasdaq: ANIX
  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisors
    • Breast Cancer Clinical Advisory Board
    • Cancer Business Advisory Board
  • Technologies
    • CAR-T
      • Introduction
      • Markets
      • Science
      • Collaborators
    • Cancer Vaccines
      • Introduction
      • Markets
      • Science
      • Collaborators
      • Breast Cancer Clinical Advisory Board
  • Pipeline
  • Investors
    • Overview
    • News Releases
    • Invest in the Future of Cancer Immunotherapy & Women’s Health
    • Events & Presentations
      • Events
      • Corporate Presentation
    • Stock Information
      • Quote
      • Charts
      • Historical Data
      • Analyst Coverage
    • SEC Filings
      • SEC Filings
    • Financial Reports
      • Annual Reports
      • Quarterly Reports
    • Corporate Governance
      • Governance Documents
      • Committee Charters
  • News
    • Press Releases
    • Anixa In The News
    • Publications
    • YouTube Channel
  • Contact Us

Annual Reports

Investors

Investors

  • Overview
  • News Releases
  • Invest in the Future of Cancer Immunotherapy & Women’s Health
  • Events & Presentations
    • Events
    • Corporate Presentation
  • Stock Info
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
  • Financial Reports
    • Annual Reports
    • Quarterly Reports
  • Governance
    • Governance Documents
    • Committee Charters
  • Investor Resources
    • Investor FAQs
    • Email Alerts
    • Fact Sheet
    • Contact IR
    • RSS News Feed
  • Financial Reports

  • Annual Reports
  • Quarterly Reports
Filter Filings:
Date Form Description Docs XBRL Pages
12/07/16 10-K Annual report pursuant to Section 13 and 15(d)
Related Documents
EX-4.2
EX-10.19
EX-10.20
EX-10.21
EX-21
EX-23.1
EX-31.1
EX-31.2
EX-32.1
EX-32.2
EX-99.1
EX-99.2
EX-99.1
HTML PDF 138
12/23/15 10-K Annual report pursuant to Section 13 and 15(d)
Related Documents
EX-21
EX-23.1
EX-31.1
EX-31.2
EX-32.1
EX-32.2
HTML PDF XBRL Viewer XLS XBRL Files 97
01/29/15 10-K/A Annual report pursuant to Section 13 and 15(d)
Related Documents
EX-23.1
EX-31.1
EX-31.2
EX-32.1
EX-32.2
HTML PDF 15
01/29/15 10-K Annual report pursuant to Section 13 and 15(d)
Related Documents
EX-21
EX-31.1
EX-31.2
EX-32.1
EX-32.2
HTML PDF XBRL Viewer XLS XBRL Files 101
04/16/14 10-K/A Annual report pursuant to section 13 and 15(d)
Related Documents
EX-31
EX-31
EX-32
EX-32
HTML PDF 41
01/17/14 10-K/A Annual report pursuant to section 13 and 15(d) HTML PDF XBRL Viewer XLS XBRL Files 6
01/16/14 10-K Annual report pursuant to section 13 and 15(d)
Related Documents
EX-3
EX-21
EX-23
EX-31
EX-31
EX-32
EX-32
HTML PDF 111
08/27/13 ARS Annual report to security holders HTML PDF 108
01/29/13 10-K Annual report pursuant to section 13 and 15(d)
Related Documents
EX-3
EX-10
EX-10
EX-10
EX-10
EX-10
EX-10
EX-10
EX-23
EX-31
EX-31
EX-32
EX-32
HTML PDF XBRL Viewer XLS XBRL Files 244
01/30/12 10-K Annual report pursuant to section 13 and 15(d)
Related Documents
EX-23.1
EX-31.1
EX-31.2
EX-32.1
EX-32.2
HTML PDF XBRL Viewer XLS XBRL Files 94
RSS
  • << Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next >>

Sign up for email Updates

Be The First to Receive Breaking News

Sign Up Now
Logo Itus
twitter logo

Latest News & Events

Jul 9, 2025

Anixa Biosciences Announces Issuance of Additional U.S. Patent for Ovarian Cancer Vaccine Technology

Read More...
Jun 23, 2025

Anixa Biosciences Initiates Dosing in Fourth Cohort in its Ovarian Cancer CAR-T Clinical Trial

Read More...
Jun 20, 2025

Anixa Biosciences to Host an Investor Webcast on June 26, 2025

Read More...
Copyrights © 2025 Anixa Biosciences, Inc.. All Rights Reserved.
twitter logo Privacy Policy Terms of Use Disclaimer Sitemap